BIO 2019 Notebook: Merck; Out-Licensing Deals; RMAT

 
• By Joseph Haas and Sue Sutter
  
Bio 2019 Notebook for Scrip
Merck & Co. exec outlines one proposed "pull incentive" for antibiotic research called the Market Entry Reward. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Advanced Therapies